By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Dendreon Corporation 

3005 First Avenue

Seattle  Washington  98121  U.S.A.
Phone: 206-256-4545 Fax: 206-256-0571


SEARCH JOBS


Industry
Biotechnology






Company News
Juno Therapeutics (JUNO) CEO and CFO Earn Hefty Bonuses; Poaches Ex-Amgen (AMGN), Dendreon (DNDN) Scientists 2/25/2015 6:12:58 AM
With the Help of Two Amgen (AMGN) Scientists, Ex-Dendreon (DNDN) CEO Launches Stealth Next-Gen Immunotherapy Startup in Seattle 2/6/2015 6:27:16 AM
Dendreon Corporation (DNDN) Enters Into Amended Agreement With Valeant (VRX) In Connection With Court-Supervised Sales Process 2/5/2015 10:51:23 AM
Valeant (VRX) Ups Bid for Dendreon (DNDN) Assets to $400 Million After Competing Offers Come In 2/5/2015 10:24:52 AM
Dendreon Corporation (DNDN) Gets $296 Million Cash Bid From Deal-Hungry Valeant (VRX) for Provenge Assets as Bankruptcy Auction Looms 1/30/2015 5:58:13 AM
Dendreon Corporation (DNDN) Provides Update On Restructuring Process 1/28/2015 11:30:20 AM
Dendreon Corporation (DNDN) Announces Strong Commercial Start To 2015 1/14/2015 7:55:05 AM
Dendreon Corporation (DNDN) Heads for Bankruptcy Auction Without $275 Million Minimum Bidder 12/31/2014 5:59:43 AM
Troubled Dendreon Corporation (DNDN) Files For Chapter 11 Bankruptcy 11/10/2014 5:56:06 AM
Struggling Dendreon Corporation (DNDN) Plunges After Warning Investors Of Debt Woes 8/13/2014 6:03:14 AM
12345678910...
//-->